16.70
Precedente Chiudi:
$16.25
Aprire:
$16.3
Volume 24 ore:
2.00M
Relative Volume:
1.90
Capitalizzazione di mercato:
$1.01B
Reddito:
$434.53M
Utile/perdita netta:
$-42.72M
Rapporto P/E:
-22.57
EPS:
-0.74
Flusso di cassa netto:
$21.88M
1 W Prestazione:
-17.00%
1M Prestazione:
-23.29%
6M Prestazione:
-35.74%
1 anno Prestazione:
-33.04%
Phreesia Inc Stock (PHR) Company Profile
Nome
Phreesia Inc
Settore
Industria
Telefono
888-654-7473
Indirizzo
1521 CONCORD PIKE, WILMINGTON
Confronta PHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PHR
Phreesia Inc
|
16.70 | 979.66M | 434.53M | -42.72M | 21.88M | -0.74 |
|
VEEV
Veeva Systems Inc
|
220.10 | 36.70B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.67 | 12.56B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
44.65 | 8.26B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.75 | 8.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.96 | 6.59B | 11.99B | 24.18M | 234.31M | 0.2956 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-09-05 | Ripresa | DA Davidson | Buy |
| 2025-08-27 | Iniziato | Mizuho | Outperform |
| 2025-01-08 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-26 | Iniziato | Truist | Buy |
| 2024-01-17 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-01-04 | Reiterato | Needham | Buy |
| 2022-12-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-09 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-13 | Iniziato | DA Davidson | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-01-06 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-09-02 | Reiterato | Needham | Buy |
| 2021-08-27 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-13 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-08 | Iniziato | Berenberg | Buy |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-04-01 | Iniziato | Robert W. Baird | Outperform |
| 2020-11-11 | Iniziato | Stephens | Overweight |
| 2020-10-27 | Iniziato | Needham | Buy |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-07-14 | Iniziato | Citigroup | Neutral |
| 2020-05-15 | Iniziato | Guggenheim | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-01-31 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-01-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-12-20 | Iniziato | Raymond James | Outperform |
| 2019-10-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-13 | Iniziato | JP Morgan | Overweight |
| 2019-08-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-12 | Iniziato | Wells Fargo | Outperform |
| 2019-08-12 | Iniziato | William Blair | Outperform |
| 2019-07-23 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Phreesia Inc Borsa (PHR) Ultime notizie
Phreesia Executive Earns National Spotlight on MM+M’s 2025 40 Under 40 - MyChesCo
Phreesia (PHR) Is Down 19.9% After Profit Turnaround And Higher Revenue OutlookHas The Bull Case Changed? - simplywall.st
Phreesia (PHR) Is Down 19.9% After Profit Turnaround But Soft Revenue OutlookWhat's Changed - Yahoo Finance UK
Why Phreesia stock plummeted by 23% today - MSN
Phreesia outlines $545M–$559M fiscal 2027 revenue target as AccessOne acquisition expands provider financing and HCP marketing reach - MSN
Phreesia stock price target lowered to $25 at Raymond James on guidance cut - Investing.com Australia
Truist Cuts Price Target on Phreesia to $29 From $36, Keeps Buy Rating - marketscreener.com
Marshall Wace LLP Has $11.91 Million Stock Holdings in Phreesia, Inc. $PHR - MarketBeat
Phreesia stock price target lowered to $25 at Raymond James on guidance cut By Investing.com - Investing.com South Africa
Phreesia (NYSE:PHR) Sees Strong Trading VolumeHere's Why - MarketBeat
PHR Analyst Ratings Update: Mizuho Lowers Price Target | PHR Sto - GuruFocus
Mizuho Lowers Phreesia (NYSE:PHR) Price Target to $28.00 - MarketBeat
Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
MercyOne partners with Phreesia to automate social needs screenings - Business Record
Robert W. Baird Cuts Phreesia (NYSE:PHR) Price Target to $25.00 - MarketBeat
PHR Stock: Baird Lowers Price Target, Maintains Outperform Ratin - GuruFocus
Barclays Initiates Coverage on Phreesia (NYSE:PHR) - MarketBeat
Phreesia (NYSE:PHR) Upgraded at Zacks Research - MarketBeat
Phreesia stock hits 52-week low at $18.17 amid market challenges - Investing.com Canada
Citizens reiterates Market Outperform rating on Phreesia stock at $34 By Investing.com - Investing.com Australia
Why Phreesia Stock Plummeted by 23% Today - Yahoo Finance
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns - Investing.com Nigeria
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns By Investing.com - Investing.com South Africa
Phreesia, Inc. SEC 10-Q Report - TradingView — Track All Markets
PHR: Citigroup Lowers Price Target While Maintaining Buy Rating - GuruFocus
Citigroup Issues Pessimistic Forecast for Phreesia (NYSE:PHR) Stock Price - MarketBeat
Is Phreesia a Hidden Opportunity After Recent Digital Patient Intake Partnerships? - Yahoo Finance
JPMorgan Chase & Co. Cuts Phreesia (NYSE:PHR) Price Target to $29.00 - MarketBeat
Needham Reiterates Buy Rating for Phreesia (PHR) with $35 Price Target | PHR Stock News - GuruFocus
Canaccord Genuity Lowers Price Target for Phreesia (PHR) | PHR S - GuruFocus
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook - Investing.com Nigeria
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook By Investing.com - Investing.com South Africa
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target - Investing.com Nigeria
Phreesia (PHR) Gains Momentum with New "Overweight" Rating by Ba - GuruFocus
Phreesia (NYSE:PHR) Reaches New 52-Week LowHere's Why - MarketBeat
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target By Investing.com - Investing.com South Africa
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech
Phreesia stock hits 52-week low at $18.17 amid market challenges By Investing.com - Investing.com South Africa
Phreesia Posts Solid Earnings But Shares Drop Anyway - Yahoo Finance
Phreesia, Inc. (NYSE:PHR) Q3 2026 earnings call transcript - MSN
Phreesia, Inc. (NYSE:PHR) Q3 2026 Earnings Call Transcript - Insider Monkey
Citizens reiterates Market Outperform rating on Phreesia stock at $34 - Investing.com
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say - sharewise.com
Phreesia Swings To Q3 Profit, Revises FY26 Outlook, Issues FY27 Guidance - RTTNews
Earnings call transcript: Phreesia Q3 2025 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa
Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Reve - GuruFocus
Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Phreesia Reports Strong Q3 2026 Earnings and Positive Outlook - TipRanks
Phreesia: Fiscal Q3 Earnings Snapshot - CTPost
Phreesia (PHR) Reports Strong Q3 with Revenue and EBITDA Growth - GuruFocus
Phreesia Inc Azioni (PHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):